Synopsis of recent research by authors named "Xinlan Li"
- Xinlan Li's recent research focuses on pharmacology and molecular biology, demonstrating significant insights into various therapeutic agents, such as bryostatin for ischemic stroke management and targeted delivery mechanisms to enhance spinal fusion outcomes.
- The author explores genetic and epigenetic factors in drug-induced cardiotoxicity, particularly the role of histone modifications like H3K27ac in the expression of cardiotoxicity-related genes following doxorubicin treatment.
- Additionally, Xinlan Li has contributed to understanding the immune response and genetic characteristics associated with infectious diseases, including studies on multidrug-resistant typhoid fever in China and the epidemiological aspects of poliovirus outbreaks in Xinjiang.